25.02.2016 SARTORIUS AG  DE0007165607

DGAP-Adhoc: SARTORIUS AG: Sartorius plans to raise share capital by use of retained earnings / 4:1 'stock split'


 
SARTORIUS AG / Key word(s): Miscellaneous/Miscellaneous 25.02.2016 12:06 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Goettingen, February 25, 2016 - The Supervisory Board and the Executive Board of Sartorius AG today resolved to submit a proposal to the Annual General Shareholders' Meeting scheduled on April 7, 2016, to increase share capital by use of retained earnings for carrying out a so-called stock split for both ordinary and preference shares at a ratio of 4:1. For this purpose, share capital would be increased accordingly by the conversion of capital reserves. Each ordinary shareholder would receive three additional ordinary shares for every Sartorius ordinary share held, without an additional payment. Every preference share owner would likewise receive three additional preference shares for every Sartorius preference share held, without an additional payment. This move will not have any impact on the amount of the company's equity as it will entail only a reclassification within equity capital. If the proposal is approved by a corresponding resolution passed by the Annual Shareholders' Meeting, the share capital of Sartorius AG would quadruple from 18,720,000 euros to 74,880,000 euros. As part of this move to increase share capital, the share in dividends (surplus and minimum dividends) would also be adjusted for preference share owners. The holders of non-voting preference shares would receive an increased dividend (surplus dividend) of 0.01 euro per preference share from the distributable annual profit; however, the dividend would at least amount to 0.02 euro per preference share (minimum dividend). This ad hoc announcement contains statements about the future development of the Sartorius Group. The content of these statements cannot be guaranteed as they are based on assumptions and estimates that harbor certain risks and uncertainties. This is a translation of the original German-language ad hoc announcement. Sartorius shall not assume any liability for the correctness of this translation. The original German ad hoc announcement is the legally binding version. Furthermore, Sartorius reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: Contact Petra Kirchhoff, Vice President of Corporate Communications +49 (0)551.308.1686 | [email protected] Andreas Theisen, Director Investor Relations +49 (0)551.308.1668 | [email protected] 25.02.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: SARTORIUS AG Weender Landstraße 94 - 108 37075 Göttingen Germany Phone: +49.(0)551-308.0 Fax: +49.(0)551-308.3289 E-mail: [email protected] Internet: www.sartorius.com ISIN: DE0007165607, DE0007165631 WKN: 716560 , 716563 Listed: Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart; Terminbörse EUREX End of Announcement DGAP News-Service ---------------------------------------------------------------------------


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.404,57 1.566,03 1.826,97 2.335,66 3.449,22 4.174,70 3.395,70
EBITDA1,2 353,20 405,00 495,80 636,70 1.134,26 1.410,40 962,70
EBITDA-Marge3 25,15 25,86 27,14 27,26 32,89 33,78
EBIT1,4 219,36 298,61 335,66 456,11 903,16 1.070,00 503,90
EBIT-Marge5 15,62 19,07 18,37 19,53 26,18 25,63 14,84
Jahresüberschuss1 159,33 197,48 218,74 299,56 426,98 655,40 290,00
Netto-Marge6 11,34 12,61 11,97 12,83 12,38 15,70 8,54
Cashflow1,7 206,51 244,52 377,19 511,53 865,81 734,20 853,60
Ergebnis je Aktie8 2,11 2,56 3,06 4,37 8,08 9,57 4,94
Dividende8 0,51 0,61 0,35 0,70 1,25 1,43 0,45
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: -

INVESTOR-INFORMATIONEN
©boersengefluester.de
Sartorius ST
WKN Kurs in € Einschätzung Börsenwert in Mio. €
716560 270,000 Halten 23.736,96
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
44,26 39,18 1,16 62,08
KBV KCV KUV EV/EBITDA
10,03 23,69 6,99 26,12
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,43 0,73 0,27 28.03.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
18.04.2024 19.07.2024 17.10.2024 16.02.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
1,12% 4,55% 1,89% -15,49%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu SARTORIUS AG  ISIN: DE0007165607 können Sie bei EQS abrufen


Medtech , 716560 , SRT , XETR:SRT